WayPoint Biomedical

WayPoint Biomedical Holdings, Inc. is a shell company that historically operated in the diagnostic testing and medical device sector. Through its primary subsidiary, WayPoint Biomedical, Inc., the company developed and commercialized rapid point-of-care tests for drugs of abuse, date rape drugs (such as the "Drink Detective"), and environmental hazards including biowarfare agents. Headquartered in Huntington Beach, California, the company was active in the mid-2000s but eventually became dormant. In December 2022, it was acquired by Genesis Capital Resources, and it currently trades on the OTC Expert Market under the symbol WYPH as a shell entity with no active business operations.